Article
Estimating TP53 Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPRO.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jun 2017
Peng Gang, Bojadzieva Jasmina, Ballinger Mandy L, Li Jialu, Blackford Amanda L, Mai Phuong L, Savage Sharon A, Thomas David M, Strong Louise C, Wang Wenyi
Abstract excerpt
Background: Li-Fraumeni syndrome (LFS) is associated with germline TP53 mutations and a very high lifetime cancer risk. Algorithms that assess a patient's risk of inherited cancer predisposition are often used in clinical counseling. The existing LFS criteria have limitations, suggesting the need for an advanced prediction tool to support clinical decision making for TP53 mutation testing and LFS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
